 | Up a level |
Journal Article
Li, Xiang 
ORCID: 0000-0001-7422-251X, Huang, Chun-Hao, Sanchez-Rivera, Francisco J., Kennedy, Margaret C., Tschaharganeh, Darjus F., Morris, John P., Montinaro, Antonella, O'Rourke, Kevin P., Banito, Ana, Wilkinson, John E., Chen, Chi-Chao, Ho, Yu-Jui, Dow, Lukas E., Tian, Sha, Luan, Wei, de Stanchina, Elisa, Zhang, Tinghu, Gray, Nathanael S., Walczak, Henning and Lowe, Scott W.
(2022).
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets.
Proc. Natl. Acad. Sci. U. S. A., 119 (17).
WASHINGTON:
NATL ACAD SCIENCES.
ISSN 1091-6490
Lovly, Christine M., McDonald, Nerina T., Chen, Heidi, Ortiz-Cuaran, Sandra, Heukamp, Lukas C., Yan, Yingjun ORCID: 0000-0001-6963-7112, Florin, Alexandra, Ozretic, Luka, Lim, Diana, Wang, Lu ORCID: 0000-0002-0073-0666, Chen, Zhao, Chen, Xi, Lu, Pengcheng, Paik, Paul K., Shen, Ronglai, Jin, Hailing, Buettner, Reinhard, Ansen, Sascha, Perner, Sven, Brockmann, Michael, Bos, Marc, Wolf, Juergen, Gardizi, Masyar, Wright, Gavin M., Solomon, Benjamin, Russell, Prudence A., Rogers, Toni-Maree, Suehara, Yoshiyuki, Red-Brewer, Monica, Tieu, Rudy, de Stanchina, Elisa, Wang, Qingguo ORCID: 0000-0002-5125-3724, Zhao, Zhongming, Johnson, David H., Horn, Leora, Wong, Kwok-Kin, Thomas, Roman K., Ladanyi, Marc and Pao, William
(2014).
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.
Nat. Med., 20 (9).
S. 1027 - 1035.
NEW YORK:
NATURE PUBLISHING GROUP.
ISSN 1546-170X
Weiskopf, Kipp, Jahchan, Nadine S., Schnorr, Peter J., Cristea, Sandra, Ring, Aaron M., Maute, Roy L., Volkmer, Anne K., Volkmer, Jens-Peter, Liu, Jie, Lim, Jing Shan, Yang, Dian, Seitz, Garrett, Wu, Di, Jude, Kevin, Guerston, Heather, Barkal, Amira, Trapani, Francesca, George, Julie, Poirier, John T., Gardner, Eric E., Miles, Linde A., de Stanchina, Elisa, Lofgren, Shane M., Vogel, Hannes, Winslow, Monte M., Dive, Caroline ORCID: 0000-0002-1726-8850, Thomas, Roman K., Rudin, Charles M., van de Rijn, Matt, Majeti, Ravindra, Garcia, K. Christopher, Weissman, Irving L. and Sage, Julien
(2016).
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.
J. Clin. Invest., 126 (7).
S. 2610 - 2621.
ANN ARBOR:
AMER SOC CLINICAL INVESTIGATION INC.
ISSN 1558-8238